This article highlights ways of improving advanced research and development (R&D) of malaria drugs to speed up their eventual licensing and use. Public-private partnerships are boosting funding for such R&D and increasing the number of drugs being developed. But better administration and funding are also needed to ensure new drugs are tested adequately in the field, including their use in combination with other drugs. The authors also stress the need for more involvement by scientists and organisations in developing countries. The article is part of a special supplement published in the 19 August 2004 issue of Nature.


Related topics